|
| Thursday, April 7, 2022 |
|
|
Legend Capital's Portfolio Company Recbio Lists on HKEX Successfully |
| On 31 March 2022, Legend Capital's portfolio company Jiangsu Recbio Technology Co., Ltd. ("Recbio", stock code: 2179.HK), a leading novel vaccines company, went public on the Hong Kong Stock Exchange. more info >> |
|
| Thursday, March 3, 2022 |
|
|
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital |
| On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188 million Series B+ equity financing, jointly led by Legend Capital. more info >> |
|
| Wednesday, March 2, 2022 |
|
|
Inceptio Technology Completes Financing of US$188 Million, Jointly Led by Legend Capital |
| On 28 February 2022, Inceptio Technology, an autonomous driving truck technology and operation company, announced its completion of a US$188 million Series B+ equity financing, jointly led by Legend Capital. more info >> |
|
| Thursday, December 16, 2021 |
|
|
Legend Capital's Portfolio Company SF Intra-city Successfully Listed on HKEx |
| On December 14, Legend Capital portfolio company SF Intra-city (09699.HK) successfully listed on the Hong Kong Stock Exchange (HKEx). SF Intra-city issued a total of 131 million shares at an issue price of HK$16.42 per share. The net proceeds from the global offering are approximately HK$2031.3 million. more info >> |
|
| Friday, November 19, 2021 |
|
|
Legend Capital Leads Sailner 3D's Pre-A Funding |
| Recently, Zhuhai Sailner 3D Technology Co., Ltd. ("Sailner 3D"), a leading industrial-grade color 3D printing company with independent core technology in China, announced its completion of a pre-A round financing of over RMB100 million led by Legend Capital. The funds will be used for deepening existing business and expanding new business. more info >> |
|
| Monday, November 15, 2021 |
|
|
Aohua Endoscopy, a Leading Endoscope Company Invested by Legend Capital, Successfully Listed on China's STAR Market |
| On November 15th, Aohua Endoscope (688212.SH), which invested by Legend Capital, was successfully listed on the Science and Technology Innovation Board (STAR Market) in China. The total number of public offering of Aohua Endoscopy is 33.34 million shares with an offering price set at RMB22.5 per share. more info >> |
|
| Friday, November 12, 2021 |
|
|
Legend Capital Leads TuringQ Pre-A Funding |
On November 10th, TuringQ, China's first photonic quantum computing company, announced its completion of a pre-A round of financing of several hundred million yuan, led by Legend Capital. The funds will be mainly used for R&D and commercialization of quantum algorithms.
more info >> |
|
| Friday, October 8, 2021 |
|
|
Legend Capital leads ForQaly Medical's Series B financing |
| ForQaly Medical (hereinafter referred to as "ForQaly"), located in Shanghai Zhangjiang International Medical Zone, is a leading high-tech company focused on developing micro-traumatic circulatory assistant devices. more info >> |
|
| Monday, September 27, 2021 |
|
|
Legend Capital is reaping the rewards in its logistics and supply chain investment |
| In recent years, the logistics and supply chain industry has ushered in many important capital events, with a lot of companies went public in fields like express, supply chain, freight platform, aviation logistics and automatic driving. more info >> |
|
| Tuesday, September 14, 2021 |
|
|
Legend Capital Led a New Round of Investment of Etana |
| Legend Capital led a new round of investment of PT Etana Biotechnologies Indonesia (Etana), along with Innovent Biologics, Inc. (Innovent) (HKEX: 01801), and a consortium led by UOB Venture Management (UOBVM). more info >> |
|
|
|
